Regulators flag second potential carcinogen in China-made heart drug
European and North American regulators have said they are examining a second potentially cancer-causing substance in a commonly-used blood pressure drug made by Chinese firm Zhejiang Huahai Pharmaceuticals.
0 comments:
Post a Comment